4D Molecular Therapeutics

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

About

4D Molecular Therapeutics is a biotechnology company.The Company designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

Mission

4D Molecular Therapeutics' core mission is centered around revolutionizing the field of gene therapy by developing targeted and optimized adeno-associated virus (AAV) vectors for various genetic diseases. Their primary objective is to create transformative, life-altering treatments for patients suffering from severe genetic disorders, with a focus on precision and efficacy. By leveraging their cutting-edge Therapeutic Vector Evolution platform, 4D Molecular Therapeutics aims to advance the boundaries of gene therapy and improve the quality of life for countless individuals affected by these debilitating conditions.

Employee Benefits

Core Values

  • Innovation: 4D Molecular Therapeutics values innovation and encourages its employees to think outside the box and explore new ideas to advance the field of gene therapy.
  • Collaboration: Collaboration is key to 4D Molecular Therapeutics's success, with a focus on teamwork and open communication to achieve common goals.
  • Patient focus: 4D Molecular Therapeutics is dedicated to improving the lives of patients through its innovative gene therapy solutions, putting the needs of patients at the forefront of its mission.
  • Diversity and inclusion: 4D Molecular Therapeutics values diversity and inclusivity, fostering a culture that embraces different perspectives and backgrounds to drive innovation and success.

4D Molecular Therapeutics

Leadership

COO at 4D Molecular Therapeutics

Theresa Janke

COO
Chief Scientific Officer & Therapeutic Area Head at 4D Molecular Therapeutics

Peter Francis

Chief Scientific Officer & Therapeutic Area Head
Ophthalmology at 4D Molecular Therapeutics

John Milligan

Ophthalmology

Open Jobs

No items found.
Location
Emeryville, CA
N/A
Company Size
101-250
N/A
Revenue Range
$10M to $50M
N/A
Valuation
N/A
Founded
2013-01-01
N/A
Current Status
IPO
N/A
Work Mode
Open Roles
7
Hiring Now
Hiring now

Funding

Total Funding
$
174999995
Funding Rounds
4
Num Investors
3
Work Mode
IPO Status
Public
Funding Stage
IPO
Last Funding Date
2020-06-16
Last Funding Type
Series C
Hiring Now
Hiring now
Track & Research 4D Molecular Therapeutics for Your Next Interview
Start Tracking for Free

Want Jobs in Your Inbox?

Sign up for the Teal newsletter and get career guidance and new jobs weekly!
Thank you! Your submission has been received!
Oops! Please provide a correct email address